483 Recruiting Trials

Clinical Trials
for Cancer in Minnesota

483 clinical trials for Cancer are currently recruiting participants at study sites in Minnesota. Study-related care is provided at no cost.

483
Recruiting trials
336
Study sites
54
Cities
239
Industry-sponsored
162
Phase 2
165
Phase 3

Cancer clinical trials in Minnesota: what to expect

Cancer is the single largest area of clinical research, and nearly every recruiting cancer trial is written for one cancer type at one stage. Most test a new drug or combination against the current standard treatment: targeted medicines matched to a mutation found in the tumor, immunotherapies that help the immune system recognize cancer cells, antibody-drug conjugates and cell therapies. Others study surgery and radiation techniques, ways to reduce side effects, and screening or prevention in people at higher risk.

In Minnesota, recruiting cancer studies are concentrated in Rochester, Minneapolis, Saint Louis Park and Saint Paul, with sites in 50 other cities. 239 of the 483 are run by a drug or device company, which usually means a larger study with travel reimbursement; the rest are academic or hospital-led.

Who cancer trials usually look for

Every listing names the cancer type and stage it enrolls, and most also state how many earlier treatments you may have had: some are for people newly diagnosed, many are for cancer that has come back or spread after a first treatment stopped working. Targeted-therapy trials require a specific result on tumor testing, which the site can arrange if it has not been done. Trials generally ask that you are well enough for daily activity (a "performance status" the doctor scores), that blood counts and liver and kidney function are adequate, and that a few weeks have passed since your last treatment.

Having advanced or metastatic cancer does not rule you out. A large share of recruiting trials are designed specifically for it.

What taking part involves

Screening reviews your pathology and scans, often with new blood work and sometimes a fresh biopsy. Treatment then follows a cycle, typically every two or three weeks, with scans every six to twelve weeks to measure the response. Early-phase trials have more frequent visits at the start. The study drug and study-specific tests are provided at no cost; standard care that you would receive anyway is usually billed to insurance as normal. A placebo on its own is rare in cancer trials: when there is one, it is added to the standard treatment, and the consent form says so.

Questions worth asking the study team

Whether the trial is randomized and what the comparison treatment is; what happens if the cancer grows during the study; whether you can keep receiving the drug afterward if it is working; how the trial fits with the plan your own oncologist has suggested; and what travel or lodging support is offered. Your oncologist can also refer you directly.

Showing 20 of 483 recruiting Cancer trials in Minnesota

Pan Tumor Rollover Study
PHASE2 Huntsville, Alabama +4 sites NCT03899155
This trial is looking for patients with cancer who have had a good response to previous treatments. Participants will continue receiving nivolumab alone or in combination with other cancer therapies to study long-term safety.
Recruiting
Capturing Food Intake in Patients Undergoing Radiation Therapy for Cancer
NA Minneapolis, Minnesota NCT07682714
This trial is looking for adults who are starting radiation therapy for cancer. Participants will use an app to track what they eat during their treatment.
Recruiting
Avera Cancer Sequencing and Analytics Protocol (ASAP)
N/A Marshall, Minnesota +4 sites NCT05142033
This trial is looking for adults who are either being monitored for a precancerous condition or have been diagnosed with cancer. Participants will provide samples for testing that helps understand cancer better and may improve future treatments.
Recruiting
Connect for Cancer Prevention Study (Connect)
N/A Denver, Colorado +4 sites NCT04609072
This trial is looking for adults between 30 and 70 years old who have never had cancer. Participants will help researchers learn about cancer risk by answering online health surveys and donating blood, urine, and saliva samples.
Recruiting
Multi-Cancer Detection Observational Cohort Study
N/A Rochester, Minnesota +2 sites NCT06962995
This trial is looking for adults who have had or are scheduled for a multi-cancer detection test. Participants will help researchers understand how this test works in real-life healthcare settings.
Recruiting
INTERogating Cancer for Etiology, Prevention and Therapy Navigation
N/A Rochester, Minnesota +4 sites NCT06008392
This trial is looking for people with a confirmed diagnosis of cancer. Participants will provide samples like blood or tissue to help researchers understand cancer better and improve treatments.
Recruiting
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
N/A Coon Rapids, Minnesota +4 sites NCT05181826
This trial is looking for adults to provide blood samples for research. These samples will help researchers understand how certain markers relate to different diseases, including cancer.
Recruiting
Childhood Cancer Survivor Study
N/A Birmingham, Alabama +4 sites NCT01120353
This trial is looking for childhood cancer survivors who were diagnosed before age 21 and survived for at least five years. Participants will be followed to understand the long-term effects of their cancer treatments.
Recruiting
Integrated Cancer Repository for Cancer Research
N/A Greenwood Village, Colorado +4 sites NCT02012699
This trial is looking for adults who have a history of cancer, are at risk for developing cancer, or are healthy individuals. Participants will provide consent and may help advance cancer research by sharing data and samples.
Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
PHASE3 Birmingham, Alabama +4 sites NCT06058377
This trial is looking for women with hormone receptor positive, HER2 negative stage II-III breast cancer. Participants will receive standard chemotherapy along with an immunotherapy drug called durvalumab to see if it helps prevent cancer from coming back.
Recruiting
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
PHASE3 Mobile, Alabama +4 sites NCT06510374
This trial is looking for people with intermediate risk non-muscle invasive bladder cancer. Participants will either receive a treatment called Nadofaragene Firadenovec or be monitored without treatment.
Recruiting
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
PHASE3 Fairbanks, Alaska +4 sites NCT06758401
This trial is looking for people with advanced lung cancer who have high levels of a specific protein called PD-L1. Participants will receive a combination treatment of two medications or just one and will be monitored regularly at a clinic.
Recruiting
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
PHASE3 Minneapolis, Minnesota +4 sites NCT06915025
This trial is looking for women aged 18 and older who have been diagnosed with advanced ovarian, fallopian tube, or peritoneal cancer. Participants will receive a new treatment called IMNN-001 along with standard chemotherapy to see how effective and safe it is.
Recruiting
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
PHASE3 Birmingham, Alabama +4 sites NCT07190248
This trial is looking for people with a type of lung cancer called non-small cell lung cancer. Participants will receive a combination of two treatments to see if they can help them live longer without the cancer getting worse.
Recruiting
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
PHASE3 Little Rock, Arkansas +4 sites NCT06312137
This trial is looking for adults with a type of lung cancer called non-small cell lung cancer who did not have a complete response after surgery. Participants will receive medications to see if adding sacituzumab to pembrolizumab helps them stay cancer-free longer.
Recruiting
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
PHASE3 Los Angeles, California +4 sites NCT06340568
This trial is looking for women with recurring endometrial cancer. Participants will either receive the drug BNT323 or certain types of chemotherapy to see how well they work.
Recruiting
A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
PHASE3 Daphne, Alabama +4 sites NCT06646276
This trial is looking for people with extensive-stage small cell lung cancer. Participants will receive one of two different treatment combinations and will be monitored for their health and tumor response.
Recruiting
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
PHASE3 Birmingham, Alabama +4 sites NCT06824467
This trial is looking for women with certain types of ovarian cancer who have had previous chemotherapy. Participants will receive a treatment to see if it helps them live longer without their cancer worsening.
Recruiting
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
PHASE3 Mobile, Alabama +4 sites NCT06952504
This trial is looking for people with advanced or recurring endometrial cancer that has specific characteristics. Participants will receive a combination of two medicines, sacituzumab tirumotecan and pembrolizumab, to see if it helps them live longer or keeps the cancer from worsening.
Recruiting
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
PHASE3 Chandler, Arizona +4 sites NCT07291037
This trial is looking for patients with advanced lung cancer that tests positive for a specific protein. Participants will receive either datopotamab deruxtecan or docetaxel as treatment.
Recruiting

Where the Cancer studies are in Minnesota

  • Mayo Clinic in Rochester, Rochester119 trials
  • Mayo Clinic, Rochester67 trials
  • Regions Hospital, Saint Paul65 trials
  • Mercy Hospital, Coon Rapids60 trials
  • Park Nicollet Clinic - Saint Louis Park, Saint Louis Park60 trials
  • Abbott-Northwestern Hospital, Minneapolis59 trials

Counts are recruiting studies listing at least one site in Minnesota, from ClinicalTrials.gov, refreshed every two days.

Cancer clinical trials in Minnesota: common questions

How many Cancer clinical trials are recruiting in Minnesota?
TrialFinder currently lists 483 recruiting Cancer clinical trials with study sites in Minnesota. Results are updated regularly from ClinicalTrials.gov, the official U.S. registry of clinical studies.
Where are Cancer clinical trials located in Minnesota?
Study sites for the Cancer trials listed on this page include Minneapolis, Marshall, Rochester, Coon Rapids. Each trial page lists every participating site with contact details, so you can find the location closest to you.
Do I need insurance to join a Cancer clinical trial in Minnesota?
No. Study-related care is covered by the trial sponsor at no cost to participants, including the study treatment, required lab tests and study visits. Many Cancer trials in Minnesota also compensate participants for time and travel. Health insurance is not required to search or enroll.
How do I qualify for a Cancer clinical trial in Minnesota?
Each study sets its own criteria based on age, Cancer diagnosis details, prior treatments, current medications and general health. The fastest way to find out is to contact a research site directly — most will pre-screen you by phone in 10 to 15 minutes at no charge. You can also create a free TrialFinder profile to be matched automatically.
Will I get a placebo instead of cancer treatment?
Almost never. Cancer trials compare a new treatment with the current standard treatment, or add the study drug to standard treatment. When a placebo is used it is on top of standard care, and the consent form states this before you decide.
Can I join a cancer trial if my cancer has spread?
Yes. Many recruiting cancer trials are written for advanced or metastatic disease, including people whose earlier treatments have stopped working. The listing states the stage and prior treatments it accepts.
Do I have to stop my current cancer treatment to join a trial?
It depends on the trial. Some enroll people whose current treatment has stopped working, some add the study drug to the treatment you are on, and some are for people who have not started treatment yet. Ask the study team before changing anything.
Are Clinical Trials Safe? What Patients Should Know
How clinical trial safety works — phases, IRB oversight, informed consent, and your right to withdraw — plus the real risks and questions to ask.
How to Know If You Qualify for a Clinical Trial
Every trial has eligibility criteria based on diagnosis, age, and medical history. Here's how to tell if you qualify — and what to do if you're not sure.
Clinical Trials Without Insurance: What You Need to Know
Clinical trials cover the cost of study-related care, making them one of the few ways to access treatment without health insurance. Here's what's covered.
All guides →

Check Your Eligibility

Create a free profile and our AI will match you to Cancer trials near you in Minnesota.

Get Matched — Free
No insurance required

Breast cancer trials test new chemotherapy regimens, immunotherapy combinations, targeted therapies, and early-detection methods across all stages of breast cancer.

All Cancer trials →